To What Extent does CRISPR/Cas9 Truly Elevate Target Efficiency and Revolutionize Drug Discovery?

Leyao Gao

doi:10.62051/d0esqn43

Authors

Leyao Gao

DOI:

https://doi.org/10.62051/d0esqn43

Keywords:

bioinformatics; CRISPR/Cas9; drug discovery; target efficiency; gene editing; cancer research; antimicrobial resistance; in silico prediction tools.

Abstract

The emergence of the CRISPR/Cas9 system has ushered in a new era of genetic editing with vast implications for both therapeutic interventions and drug discovery. This essay explores the extent to which CRISPR/Cas9 elevates target efficiency and revolutionizes drug discovery. While this technology offers unprecedented efficiency, precision, and programmability in genome editing, concerns about off-target effects have arisen. The essay discusses the transformative impact of CRISPR/Cas9 in drug discovery, particularly in cancer research and combating antimicrobial resistance. It also highlights strategies for detecting and mitigating off-target effects, such as in silico prediction tools, experimental methods, and precision-enhancing techniques. Ultimately, CRISPR/Cas9’s potential is undeniable, but its full realization depends on ongoing research and refinement to optimize specificity and revolutionize the field of drug discovery.

Downloads

Download data is not yet available.

References

Andrew Scott. A CRISPR path to drug discovery. NATURE. 2018, 555.

Khurana, A., Sayed, N., Singh, V., Khurana, I., Allawadhi, P., Rawat, P. S., Navik, U., Pasumarthi, S. K., Bharani, K. K., & Weiskirchen, R. A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery. Journal of Cellular Biochemistry, 2022, 123 (10), 1674 – 1698.

Guo, C., Ma, X., Gao, F., & Guo, Y. Off-target effects in CRISPR/Cas9 gene editing. Frontiers in Bioengineering and Biotechnology, 11.

Sherkatghanad, Z., Abdar, M., Charlier, J., & Makarenkov, V. Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review. Briefings in Bioinformatics, 2023, 24 (3).

Hendriks, D., Clevers, H., & Artegiani, B. CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids. Cell Stem Cell, 2020, 27 (5), 705 – 731.

Zhang, S., Li, X., Lin, Q., & Wong, K. C. Synergizing CRISPR/Cas9 off-target predictions for ensemble insights and practical applications. Bioinformatics, 2018, 35 (7), 1108 – 1115.

Bikard, D., & Barrangou, R. Using CRISPR-Cas systems as antimicrobials. Current Opinion in Microbiology, 2017, 37, 155 – 160.

Yan, M. Y., Yan, H. Q., Ren, G. X., Zhao, J. P., Guo, X. P., & Sun, Y. C. CRISPR-Cas12a-Assisted Recombineering in Bacteria. Applied and Environmental Microbiology, 2017, 83 (17).

Kim, D., Luk, K., Wolfe, S. A., & Kim, J. S. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases. Annual Review of Biochemistry, 2019, 88 (1), 191 – 220.

Wang, D., Zhang, C., Wang, B., Li, B., Wang, Q., Liu, D., Wang, H., Zhou, Y., Shi, L., Lan, F., & Wang, Y. Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning. Nature Communications, 2019, 10 (1).

Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Research, 2014, 24 (6), 1012 – 1019.